AKT1 and melanoma: Obesity, characterized by chronic low‐grade inflammation and adipokine imbalance, promotes melanoma progression by driving metabolic reprogramming (e.g., FAO) and activating pathways such as PI3K/Akt signaling, promoting tumor aggressiveness, and modulating immune responses.